Differences in DNA methylation of insulin-like growth factor 2 and cadherin 13 in patients with preeclampsia.

Abstract

In a previous mass spectrometry study of our research group, 25 proteins were found to be differentially expressed in cerebrospinal fluid of patients with preeclampsia compared to controls. The objective of the current study was to investigate DNA methylation of the genes encoding for the former mentioned proteins in an independent dataset. In a nested case-control study of the Rotterdam Periconceptional Cohort, placental tissue, umbilical cord white blood cells and human umbilical vein endothelial cells (HUVEC) were obtained of 13 patients with early-onset preeclampsia, 16 patients with late-onset preeclampsia and 83 normotensive controls (27 patients with fetal growth restriction, 20 patients with spontaneous preterm birth and 36 uncomplicated pregnancies). DNA methylation of 783CpGs in regions of 25 genes was measured. DNA methylation of selected candidate genes in early- and late-onset preeclampsia compared to fetal growth restriction, spontaneous preterm birth and uncomplicated controls. From the 783CpGs of the 25 selected genes, 15CpGs were differentially methylated between early-onset preeclampsia and spontaneous preterm birth (3.80 E-5≤p≤0.036). Four CpGs were differentially methylated between early-onset preeclampsia and fetal growth restriction (0.0002≤p≤0.037) and 13CpGs were differentially methylated between early onset preeclampsia and uncomplicated controls (0.0001≤p≤0.04). Differences in DNA methylation were found in placental tissue, umbilical cord white blood cells and HUVEC of patients with early onset preeclampsia compared to (un)complicated controls, but not in patients with late-onset preeclampsia. The genes showing the largest differential methylation encode insulin-like growth factor 2 binding protein and receptor and cadherin 13.